Zhang Wan, Zhou Linjun, Li Chunyu, Deng Zixin, Qu Xudong
Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, School of Pharmaceutical Sciences, Wuhan University, Wuhan, China.
Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, School of Pharmaceutical Sciences, Wuhan University, Wuhan, China.
Methods Enzymol. 2019;622:271-292. doi: 10.1016/bs.mie.2019.02.016. Epub 2019 Mar 12.
Polyketides have valuable pharmaceutical properties and exhibit a high degree of structural diversity. This diversity can trace back to the polyketide synthesis assembly line, in which the gatekeeper domain ATs strictly control the selection and incorporation of the simple extender units. And thus engineering attempts targeted on ATs have been made to obtain novel polyketide skeletons, which are useful for pharmaceutical and cellular function studies. So far, method of combinatorial biosynthesis has become the most attractive and effective way, particularly through alteration of the acyltransferase (AT) specificity. Herein, upon the complex structures of a broadly selective SpnD-AT, we introduce a structure-directed protocol to manipulate the well-studied EryAT6 to broaden its substrate scope. This protocol can also be generalized to canonical AT domains engineering in the generation of novel and useful chemical probes for dissecting cellular functions.
聚酮化合物具有重要的药用特性,并呈现出高度的结构多样性。这种多样性可追溯到聚酮化合物合成装配线,其中守门结构域酰基转移酶(ATs)严格控制简单延伸单元的选择和掺入。因此,人们针对ATs进行了工程改造尝试,以获得新型聚酮化合物骨架,这对于药物和细胞功能研究很有用。到目前为止,组合生物合成方法已成为最具吸引力和最有效的方法,特别是通过改变酰基转移酶(AT)的特异性。在此,基于一种广泛选择性的SpnD-AT的复杂结构,我们引入了一种结构导向的方案来操纵已深入研究的EryAT6,以拓宽其底物范围。该方案也可推广到标准AT结构域工程,用于生成剖析细胞功能的新型有用化学探针。